$0.365
-0.0101 (-2.69%)
At Close: Aug 04, 2026
ZenaTech, Inc. (NASDAQ: ZENA) Software Company Acquisition
12:03pm, Wednesday, 23'rd Oct 2024 InvestorsHub
ZenaTech, Inc. (NASDAQ: ZENA) Software Company Acquisition
Miami, FL – October 23, 2024 -- InvestorsHub NewsWire – EmergingGrowth.com, a leading independent small cap media portal with an extensive history of providing unparalleled content for the Emerging Growth markets and companies, reports on ZenaTech, Inc. (NASDAQ: ZENA).
ZenaTech, Inc. (NASDAQ: ZENA), a technology company specializing in AI (Artificial Intelligence) drone...
Elite Pharmaceuticals' Generic Adderall(R) Receives Marketing Approval from the Israeli Ministry of Health
04:41pm, Thursday, 10'th Oct 2024
Northvale, New Jersey--(Newsfile Corp. - October 10, 2024) - Elite Pharmaceuticals, Inc. (OTCQB: ELTP) ("Elite" or the "Company"), a specialty pharmaceutical company developing niche generic products,
Elite Pharmaceuticals Announces Commercial Launch of Acetaminophen and Codeine Phosphate Tablets
07:30am, Monday, 07'th Oct 2024
Northvale, New Jersey--(Newsfile Corp. - October 7, 2024) - Elite Pharmaceuticals, Inc. (OTCQB: ELTP) ("Elite" or the "Company"), a specialty pharmaceutical company developing niche generic products
Elite Pharmaceuticals Announces Commercial Launch of Generic Methotrexate Sodium
07:00am, Tuesday, 27'th Aug 2024
Northvale, New Jersey--(Newsfile Corp. - August 27, 2024) - Elite Pharmaceuticals, Inc. (OTCQB: ELTP) ("Elite" or the "Company"), a specialty pharmaceutical company developing niche generic products,
Elite Pharmaceuticals (ELTP) Posts Breakeven Q1 Earnings
03:16pm, Friday, 16'th Aug 2024
Strength in Elite Pharmaceuticals' (ELTP) Manufacturing fees drive its fiscal first-quarter performance.
Elite Pharmaceuticals, Inc. (ELTP) Q1 2025 Earnings Call Transcript
01:25pm, Thursday, 15'th Aug 2024
Elite Pharmaceuticals, Inc. (OTCQB:ELTP) Q1 2025 Earnings Conference Call August 15, 2024 11:30 AM ET Company Participants Nasrat Hakim – President and Chief Executive Officer Carter Ward – Chief
Conference Call Scheduled for Thursday, August 15 at 11:30 AM EDT Northvale, New Jersey--(Newsfile Corp. - August 14, 2024) - Elite Pharmaceuticals, Inc. (OTCQB: ELTP) ("Elite" or the "Company"), a sp
Financials for First Quarter of Fiscal Year 2025 Ended June 30, 2024 will be released on August 14, 2024 Northvale, New Jersey--(Newsfile Corp. - August 9, 2024) - Elite Pharmaceuticals, Inc. (OTCQB:
Zacks Initiates Coverage of Elite Pharmaceuticals With Outperform Recommendation
10:56am, Friday, 12'th Jul 2024
Discover why Zacks rates Elite Pharmaceuticals as "Outperform", being the first on Wall Street to initiate coverage on the stock. Explore ELTP's strategic partnerships, financial health, and robust pr
Elite Pharmaceuticals, Inc. (ELTP) Q4 2024 Earnings Call Transcript
08:47pm, Tuesday, 02'nd Jul 2024
Elite Pharmaceuticals, Inc. (OTCQB:ELTP) Q4 2024 Earnings Conference Call July 2, 2024 11:30 AM ET Company Participants Nasrat Hakim - President and CEO Carter Ward - CFO, Secretary and Treasurer Conf
Elite Pharmaceuticals' (ELTP) FY24 Earnings Up, Gross Margin Down
12:45pm, Tuesday, 02'nd Jul 2024
Elite Pharmaceuticals' (ELTP) overall top line benefits from revenue growth in Manufacturing fees.
Conference Call Scheduled for Tuesday, July 2 at 11:30 AM EDT Northvale, New Jersey--(Newsfile Corp. - July 1, 2024) - Elite Pharmaceuticals, Inc. (OTCQB: ELTP) ("Elite" or the "Company"), a specialty
Financials for Fiscal Year 2024 Ended March 31, 2024 will be released on July 1, 2024 Northvale, New Jersey--(Newsfile Corp. - June 26, 2024) - Elite Pharmaceuticals, Inc. (OTCQB: ELTP) ("Elite" or th
7 Strong Buy Penny Stocks to Buy Now: June 2024
06:32am, Thursday, 13'th Jun 2024
There are thousands of U.S.-listed stocks categorized as penny stocks, or stocks trading for $5 per share or less but only a few can be considered strong buy penny stocks. “Penny stock territory”
Elite Pharmaceuticals Receives FDA Approval for Generic Methotrexate
06:00am, Monday, 20'th May 2024
NORTHVALE, NJ / ACCESSWIRE / May 20, 2024 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCQB:ELTP), a specialty pharmaceutical company developing niche generic products, today announced t
Sign In
Buy ELTP